For now, retatrutide remains in clinical trials with uncertain approval timeline
CNS-VS test results after treatment are shown in Table 3
Ingredients: Water, ethylhexyl palmitate, squalane, stearic acid, cetyl alcohol, Copper Tripeptide-1 (GHK-Cu), methylsulfonylmethane, dimethyl MEA (DMAE), glyceryl stearate, PEG-100 stearate, nannochloropsis oculata extract (with pullulan, aqua, phenoxyethanol, and sodium benzoate potassium sorbate), PPG 2 myristyl ether propionate, phenoxyethanol, C10-30 cholesterol/lanosterol esters, polysorbate 80, allantoin, leucine, lavandula angustifolia (lavender) oil, aloe barbadensis (aloe vera) powder, sodium salicylate, vitamin E TPGS (tocophersolan), vitamin E (as d-alpha tocopherol plus mixed tocopherols: d-beta, d-delta and d-gamma tocopherol) 0 Reviews 0 Reviews Write a Review Write a Review GHK-Cu Crepey Skin Escape Write a Review GHK-Cu Crepey Skin Escape Additional Info & Ingredients Additional Info & Ingredients PRODUCT DETAILS: Paraben Free

Overall, the researchers found that the APP/PS1 mice treated with Dihexa exhibited a significantly better performance in comparison to the control mice when assessing the number of platform crossings
Preclinical mode-of-action studies have shown that cagrilintide and closely related experimental compounds can produce additional effects when studied alongside semaglutide in diet-induced obesity models [4]